Exclusive Interviews

In this Exclusive Interview transcript, Judith Wylie-Rosett talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about non-nutritive sweetener safety and uses, and the effect of low-calorie, sweetened beverages on cardiometabolic health.

In this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about the use of low-calorie, sweetened beverages on cardiometabolic health.

In part 1 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the safety of non-nutritive sweeteners.

In part 2 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the various users of low calorie sweeteners.

In part 3 of this Exclusive Interview, Judith Wylie-Rosett shares the results of trials studying the effects of using sweeteners in a conversation with Diabetes in Control Publisher Steve Freed.

In part 4 of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about the impact of artificial sweeteners on weight loss efforts as well as cardiometabolic health.

In part 5, the conclusion of this Exclusive Interview, Judith Wylie-Rosett talks with Diabetes in Control Publisher Steve Freed about her recommendations regarding talking about the use of sweeteners with patients who have diabetes. She also shares the highlights of her ADA presentation.

Raghu Mirmira, MD, PhD, is the director of the Center for Diabetes and Metabolic Diseases (CDMD) at Indiana University School of Medicine. Under his leadership, the NIH-funded CDMD at IU School of Medicine strives to transform health through basic and translational research while preparing healers with enhanced opportunities in diabetes research and scientific discovery. The focus of Dr. Mirmira’s research is the pathogenesis of diabetes mellitus and the biology of the islet. His most recent areas of interest include islet stress pathways in Type 1 diabetes and how these pathways contribute to the production of neoantigens and the activation of autoimmune responses.

In this Exclusive Interview transcript, Raghu Mirmira talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about his work as type 1 diabetes researcher, beta cell replacement, and ER Stress.

In this Exclusive Interview, Raghu Mirmira talks with Diabetes in Control publisher Steve Freed during the ADA 2018 convention in Orlando about his research in type 1 diabetes, beta cell replacement, and ER Stress.